"10.1371_journal.pone.0107455","plos one","2014-09-24T00:00:00Z","Dean A Fennell; Scott P Myrand; Tuan S Nguyen; David Ferry; Keith M Kerr; Perry Maxwell; Stephen D Moore; Carla Visseren-Grul; Mayukh Das; Marianne C Nicolson","Leicester University Hospital, Leicester, United Kingdom; Eli Lilly and Company, Indianapolis, IN, United States of America; New Cross Hospital, Wolverhampton, United Kingdom; Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom; Queens University, Belfast, United Kingdom; Almac Diagnostics, Craigavon, United Kingdom; Eli Lilly and Company, Houten, Netherlands; Eli Lilly and Company, Basingstoke, United Kingdom","Conceived and designed the experiments: SPM TSN SDM MD. Performed the experiments: DAF DF KMK PM MCN. Analyzed the data: SDM TSN. Contributed reagents/materials/analysis tools: SDM. Wrote the paper: DAF SPM TSN DF KMK PM SDM CVG MD MCN. Contributed to data interpretation: DAF SPM TSN DF KMK PM SDM CVG MD MCN.","The study was funded by Eli Lilly and Company, the manufacturer of pemetrexed. Medical Writing Services from Trilogy Writing and Consulting were funded by Eli Lilly. The study was sponsored by Eli Lilly and Company. CVG, MD, SPM, TSN, and DF are employees at Eli Lilly and also own Eli Lilly stock. DF and MCN have received research grants for their institution from Eli Lilly. DAF and DF have been paid by Eli Lilly for consultancy. DAF, DF, and KMK have received support for travel to meetings for the study or other purposes from Eli Lilly. KMK and MCN have been provided with writing assistance, medicines, equipment, or administrative support from Eli Lilly. DAF and KMK have also received speaker honoraria from Eli Lilly. DAF has also received payment for development of educational presentations from Eli Lilly. MCN was the principal investigator of the study. DF has also received consultancy payment from Astra Zeneca, Novartis, Roche and Sanofi. KMK has received consultancy payment from Astra Zeneca, Boehringer Ingelheim, Glaxo Smith Kline, Novartis, Pfizer, and Roche. MCN has worked as consultant/advisor for or has received speaker honoraria or research grants from Abbott, Astra Zeneca, Boehringer Ingelheim, Glaxo-SmithKline, Merck Serono, Pfizer, Roche, and Synta. DF has received speaker honoraria from Sanofi and Roche. SDM was an employee of Almac Diagnostics at the time of the study and has been paid for the generation of study data. PM has no conflicts of interest to disclose. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials.","2014","09","Dean A Fennell","DAF",10,TRUE,4,5,2,10,TRUE,FALSE,FALSE,0,NA,FALSE
